Brief: Evonik And Invitria Partner To Expand Access To Animal-Free Albumin For Biopharma Innovation
17/11/2025 13:21
Nov 17 (Reuters) - EVONIK INDUSTRIES AG EVKn.DE: EVONIK AND INVITRIA PARTNER TO EXPAND ACCESS TO ANIMAL-FREE ALBUMIN FOR BIOPHARMA INNOVATION Further company coverage: [EVKn.DE] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on Evonik Industries AG
See all newsBrief: Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site
German chemical industry confidence improves sharply in June, Ifo says (updated)
German chemical sector gets temporary lift from Middle East disruptions, Ifo says
Evonik raise full-year outlook as Middle East disruption hits Asian rivals (updated)
Evonik raises full-year profitability outlook after Q2 beat